EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plerixafor Engages β-Arrestin-Dependent CXCR4 Signaling to Promote Melanogenesis via β-Catenin-MITF Activation

Tsong-Min Chang, Ting-Ya Yang, Huey-Chun Huang iD

Current Issues in Molecular Biology · 17.07.2026 · 48 (7) · 730

DOI: 10.3390/cimb48070730 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 17.07.2026. Verfasst von Tsong-Min Chang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Cosmetology, HungKuang University, Taichung City 433304, Taiwan. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, China Medical University, Ministry of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plerixafor is a clinically approved CXCR4 antagonist that mobilizes hematopoietic stem cells by disrupting CXCL12/CXCR4 retention signaling. However, its biochemical effects on melanocytes and pigmentation remain unexplored. We investigated how Plerixafor modulates CXCR4 signaling in melanocytes and evaluated its potential as a pro-melanogenic agent using in vitro and in vivo approaches. Human PIG1 melanocytes were treated with 10 nM Plerixafor with or without hydroquinone (HQ), followed by qPCR for MITF and tyrosinase expression, flow cytometry for CXCR4/CXCR7 and integrin profiling, transwell migration assays, β-arrestin siRNA knockdown, Western blotting, subcellular fractionation, and ChIP-qPCR for β-catenin binding to MITF regulatory regions. A murine HQ-induced depigmentation model was used to test topical Plerixafor on pigmentation, hair follicles, melanogenic gene expression, and systemic safety markers. Plerixafor significantly increased MITF and tyrosinase mRNA and enhanced melanocyte migration while counteracting HQ-induced suppression of melanogenic genes. In addition, it reduced cell-surface CXCR4 (consistent with β-arrestin-mediated receptor internalization) without altering CXCR7, c-KIT, or N-cadherin. β-Arrestin knockdown abolished Plerixafor-induced ERK phosphorylation and melanogenic responses, confirming β-arrestin dependence. Plerixafor promoted β-catenin nuclear translocation and direct β-catenin occupancy at MITF promoter/enhancer TCF/LEF motifs. In vivo, topical Plerixafor restored HQ-induced depigmentation, increased hair follicle number and melanin content, and upregulated cutaneous MITF and tyrosinase without hepatic, renal, or inflammatory toxicity. Plerixafor functions as a biased CXCR4 ligand in melanocytes, influencing the β-arrestin–β-catenin–MITF signaling axis to drive melanogenesis and re-pigmentation. These findings identify β-arrestin-dependent CXCR4 signaling as a tractable pharmacologic mechanism for therapeutic re-pigmentation in pigmentary disorders.

Schlagwörter

Stichwörter der Autor:innen

CXCR4MITFPlerixaforre-pigmentationβ-arrestinβ-catenin

Autor:innen und Institutionen

  • Department of Applied Cosmetology, HungKuang University, Taichung City 433304, Taiwan.
  • Department of Medical Laboratory Science and Biotechnology, College of Medicine, China Medical University, Taichung City 40402, Taiwan.

ORCID-Profile: Huey-Chun Huang

Förderung

  • National Science and Technology Council
  • China Medical University
  • Ministry of Science and Technology

Zitieren

APA

Chang, T. M., Yang, T. Y., & Huang, H. C. (2026). Plerixafor Engages β-Arrestin-Dependent CXCR4 Signaling to Promote Melanogenesis via β-Catenin-MITF Activation. Current Issues in Molecular Biology, 48(7), 730. https://doi.org/10.3390/cimb48070730

Vancouver

Chang TM, Yang TY, Huang HC. Plerixafor Engages β-Arrestin-Dependent CXCR4 Signaling to Promote Melanogenesis via β-Catenin-MITF Activation. Current Issues in Molecular Biology. 2026;48(7):730. doi:10.3390/cimb48070730

BibTeX
@article{Chang2026,
  author = {Chang, Tsong-Min and Yang, Ting-Ya and Huang, Huey-Chun},
  title = {Plerixafor Engages β-Arrestin-Dependent CXCR4 Signaling to Promote Melanogenesis via β-Catenin-MITF Activation},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {7},
  pages = {730},
  doi = {10.3390/cimb48070730}
}
Kostenlos starten →